PHILADELPHIA, Oct. 22, 2024 (GLOBE NEWSWIRE) — Proscia(R), a global leader in AI-enabled pathology solutions for precision medicine, was named to KLAS Research’s 2024 Emerging Solutions Top 20 list of technologies best positioned to impact the Quadruple Aim of Healthcare. Its Concentriq(R) software platform was selected by healthcare leaders across the United States for improving […]
Third Quarter 2024 Highlights: Return on Assets (annualized) improved to 0.71%, compared to 0.58% in 3Q 2023 Net interest margin (tax-equivalent) of 3.05%, compared to 2.73% in 3Q 2023 Net interest income (tax-equivalent) was $6.8 million, an increase of 7% compared to 3Q 2023 Average loans were $571.7 million, an increase of 8% compared to
PHOENIX, Oct. 22, 2024 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative flexible space and storage solutions, today announced the appointment of Worthing Jackman to the WillScot Board of Directors, effective October 22, 2024. Erik Olsson, Chairman of WillScot, commented, “We are pleased to welcome Worthing Jackman
The Esteem(R) device is the only totally implantable active middle ear implant with FDA Approval, allowing the Company to be the first to capitalize on the new codes WHITE BEAR LAKE, Minnesota, Oct. 22, 2024 (GLOBE NEWSWIRE) — Envoy Medical, Inc. (NASDAQ: COCH), a market leader in fully implanted hearing devices, today announced that the
GARDEN CITY, NY, Oct. 22, 2024 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. Past ThinkEquity conferences have featured over
DALLAS, Oct. 22, 2024 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. (NYSE:WHG) will release its third quarter 2024 earnings after the close of the New York Stock Exchange on Wednesday, October 30, 2024. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central
IRVINE, California, Oct. 22, 2024 (GLOBE NEWSWIRE) — Menlo Microsystems, Inc. (Menlo Micro), the company responsible for bringing to market the greatest electronic component innovation since the transistor with its Ideal Switch(R) technology, announced a new global distribution agreement with DigiKey, a leading global commerce distributor. Under the terms of the agreement, DigiKey becomes a
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) — Cayson Acquisition Corp (NASDAQ:CAPNU) (the “Company”) announced today that, commencing on or about October 24, 2024, holders of its units sold in the Company’s initial public offering may elect to separately trade the Company’s ordinary shares and rights included in the units. The ordinary shares and rights
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin produced by C. diff. in the gastrointestinal tract. There are up to 175,000 cases of
MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced it will present two scientific posters at the 17th Clinical Trials on